Month: September 2019

Adial Pharmaceuticals Completes Key Regulatory Milestone Prior to Commencing European Phase 3 Clinical Trial of AD04 for the Treatment of Alcohol Use Disorder

Application for pediatric investigation plan waiver validated by European Medicines Agency CHARLOTTESVILLE, VA / ACCESSWIRE / September 5, 2019 /...

error: Content is protected !!